On Dec. 27, the U.S. Food and Drug Administration issued a final guidance addressing the cyber vulnerabilities in medical devices, outlining how manufacturers should maintain security of internet-connected devices such as pacemakers and insulin pumps.
With the guidelines, the FDA said manufacturers must build cybersecurity controls into medical devices during the development process. Further, they should establish, document and maintain the identification of hazards throughout the device lifecycle as part of risk management.
